Ever since its establishment in December 2003, Genzon Investment Group (Genzon Group) has gradually evolved into an integrated enterprise group that focus on two main business units of real estate, and pharmaceuticals, and combines new material development, cold-chain logistics, sheet metal manufacturing, capital funding, start-up investment, golf and high-end services. Genzon Group is headquartered in Shenzhen, China and employs over 4,000 people.
As a core business of Genzon Group, the real estate business unit has developed portfolios with industrial, commercial real estate and residents. Over the years, it developed business complex, office buildings, residents, hotel and golf club, and gained leading advantages and experiences in real estate development and property management.
In pharmaceutical, Genzon Pharmaceutical is a modernized company who integrates medicine development, produce and sales. Currently, it owns multi-product portfolio with Chemical medicine, Chinese medicine and health care products. Its product SINOGEN, EPOSINO, WHITE-C, CHANGLEKANG, Kehuang Capsule and Bio-Efficacité ranked on the forefront of the market in terms of the market share and reputation.
Over ten years, Genzon Group adhere to the mission of “Creating a remarkable value ecosystem”, dedicated itself as a benchmarking reliable enterprise. In order to triumph in this new era and in the transforming stage in China, Genzon Group will based on the internal team building, to cooperate with all resources and to realize the industry communication. It aims to establish a value promoting ecosystem by pursuing leadership within the industry, and to become the paragon in management and business operating.